Press releases

2026

August 26

Transparency declaration

August 25

Successful placement of GBL’s €500m bond issuance with an 8-year maturity

July 30

Half-year Report 2026
Substantial progress including portfolio simplification, investments in controlled and co-controlled assets, and attractive shareholder returns

July 08

GBL completes its acquisition of a majority stake in BUKO Group, a leading platform in temporary traffic management, as part of the group's mid-term strategy execution

May 29

Report on payments to governments

May 28

GBL completes its acquisition of a co-control stake in Rayner, a leading ophthalmic MedTech specialist, as part of the group’s mid-term strategy execution

May 22

Recordati - Voluntary Totalitarian Tender Offer

May 11

Transparency declaration

May 07

Results as of March 31, 2026

May 07

Extraordinary and Ordinary General Shareholders’ Meetings of May 7, 2026

April 23

GBL acquires BUKO Group, a leading platform in temporary traffic management, as part of the group’s mid-term strategy execution

April 07

Publication of the 2025 Annual Report

April 07

Extraordinary and Ordinary General Shareholders’ Meetings of May 7, 2026

March 12

Results as of December 31, 2025

February 25

GBL exits its position in Umicore in the context of portfolio simplification, one of the group’s key strategic priorities

February 09

GBL invests in Rayner, a leading ophthalmic MedTech specialist, as part of the group’s mid-term strategy execution

January 14

Successful placement of GBL’s €500m bond issuance with a 10-year maturity

January 12

GBL further strengthens its investment team to support the execution of the mid-term strategy

November 07

Results at 30 September 2013

October 16

Transparency Declaration on 14 October 2013

October 09

Announcement of the death of M. Paul G. Desmarais

October 08

Further development of the Financial Pillar

September 27

Lauch of a 5–year convertible bond into 5 million existing treasury shares

September 27

GBL successfully places EUR 428 million bonds convertible into 5 million existing treasury shares

July 30

Half-Year Results to 30 June 2013

July 17

Threshold crossing in Umicore

June 03

GBL pursues its portfolio diversification strategy with the acquisition of 15.0% of SGS from EXOR

May 14

Successful sale of 2.7% of the share capital of GDF SUEZ

May 13

Sale by GBL of 2.7% of the share capital of GDF SUEZ

May 08

Results to 31 March 2013

March 05

Results of the year ended 31 December 2012

January 24

Successful placement by GBL of a EUR 1 billion 1.25% 4-year exchangeable bond for GDF SUEZ shares

January 24

Press releases

2026

Transparency declaration

Successful placement of GBL’s €500m bond issuance with an 8-year maturity

Half-year Report 2026
Substantial progress including portfolio simplification, investments in controlled and co-controlled assets, and attractive shareholder returns

GBL completes its acquisition of a majority stake in BUKO Group, a leading platform in temporary traffic management, as part of the group's mid-term strategy execution

Report on payments to governments

GBL completes its acquisition of a co-control stake in Rayner, a leading ophthalmic MedTech specialist, as part of the group’s mid-term strategy execution

Recordati - Voluntary Totalitarian Tender Offer

Transparency declaration

Results as of March 31, 2026

Extraordinary and Ordinary General Shareholders’ Meetings of May 7, 2026

GBL acquires BUKO Group, a leading platform in temporary traffic management, as part of the group’s mid-term strategy execution

Publication of the 2025 Annual Report

Extraordinary and Ordinary General Shareholders’ Meetings of May 7, 2026

Results as of December 31, 2025

GBL exits its position in Umicore in the context of portfolio simplification, one of the group’s key strategic priorities

GBL invests in Rayner, a leading ophthalmic MedTech specialist, as part of the group’s mid-term strategy execution

Successful placement of GBL’s €500m bond issuance with a 10-year maturity

GBL further strengthens its investment team to support the execution of the mid-term strategy

Results at 30 September 2013

Transparency Declaration on 14 October 2013

Announcement of the death of M. Paul G. Desmarais

Further development of the Financial Pillar

Lauch of a 5–year convertible bond into 5 million existing treasury shares

GBL successfully places EUR 428 million bonds convertible into 5 million existing treasury shares

Half-Year Results to 30 June 2013

Threshold crossing in Umicore

GBL pursues its portfolio diversification strategy with the acquisition of 15.0% of SGS from EXOR

Successful sale of 2.7% of the share capital of GDF SUEZ

Sale by GBL of 2.7% of the share capital of GDF SUEZ

Results to 31 March 2013

Results of the year ended 31 December 2012

Successful placement by GBL of a EUR 1 billion 1.25% 4-year exchangeable bond for GDF SUEZ shares

Launch by GBL of an exchangeable bond for GDF SUEZ shares

Headquarters

Other locations

Contact

Investor Relations

Press releases

2026

Transparency declaration

Successful placement of GBL’s €500m bond issuance with an 8-year maturity

Half-year Report 2026Substantial progress including portfolio simplification, investments in controlled and co-controlled assets, and attractive shareholder returns

GBL completes its acquisition of a majority stake in BUKO Group, a leading platform in temporary traffic management, as part of the group's mid-term strategy execution

Report on payments to governments

GBL completes its acquisition of a co-control stake in Rayner, a leading ophthalmic MedTech specialist, as part of the group’s mid-term strategy execution

Recordati - Voluntary Totalitarian Tender Offer

Transparency declaration

Results as of March 31, 2026

Extraordinary and Ordinary General Shareholders’ Meetings of May 7, 2026

GBL acquires BUKO Group, a leading platform in temporary traffic management, as part of the group’s mid-term strategy execution

Publication of the 2025 Annual Report

Extraordinary and Ordinary General Shareholders’ Meetings of May 7, 2026

Results as of December 31, 2025

GBL exits its position in Umicore in the context of portfolio simplification, one of the group’s key strategic priorities

GBL invests in Rayner, a leading ophthalmic MedTech specialist, as part of the group’s mid-term strategy execution

Successful placement of GBL’s €500m bond issuance with a 10-year maturity

GBL further strengthens its investment team to support the execution of the mid-term strategy

Results at 30 September 2013

Transparency Declaration on 14 October 2013

Announcement of the death of M. Paul G. Desmarais

Further development of the Financial Pillar

Lauch of a 5–year convertible bond into 5 million existing treasury shares

GBL successfully places EUR 428 million bonds convertible into 5 million existing treasury shares

Half-Year Results to 30 June 2013

Threshold crossing in Umicore

GBL pursues its portfolio diversification strategy with the acquisition of 15.0% of SGS from EXOR

Successful sale of 2.7% of the share capital of GDF SUEZ

Sale by GBL of 2.7% of the share capital of GDF SUEZ

Results to 31 March 2013

Results of the year ended 31 December 2012

Successful placement by GBL of a EUR 1 billion 1.25% 4-year exchangeable bond for GDF SUEZ shares

Launch by GBL of an exchangeable bond for GDF SUEZ shares

Headquarters

Other locations

Contact

Investor Relations

Half-year Report 2026
Substantial progress including portfolio simplification, investments in controlled and co-controlled assets, and attractive shareholder returns